Published: September 02, 2004

Serologicals Corporation to Present at Thomas Weisel Partners Healthcare Tailwinds 2004

Share With Friends

Serologicals Corporation today announced that it is scheduled to give an investor presentation at the Thomas Weisel Partners Healthcare Tailwinds Conference on September 10, 2004.

Bud Ingalls, Vice President, Finance and Chief Financial Officer for Serologicals Corporation, will be making the presentation, scheduled for 10:00 a.m. (ET) at The Four Seasons Hotel in Boston, MA. The presentation will be web cast live (audio only) and can be accessed through the Company's website at www.serologicals.com, or at http://www.visualwebcaster.com/event.asp?id=24348.

Serologicals Corporation, headquartered in Atlanta, Georgia, is a global provider of biological products and enabling technologies, which are essential for the research, development and manufacturing of biologically based life science products. The Company's products and technologies are used in a wide variety of innovative applications within the areas of oncology, hematology, immunology, cardiology and infectious diseases, as well as in the study of molecular biology. Serologicals has more than 650 employees worldwide, and its shares are traded on the NASDAQ national stock market under the symbol SERO.

Serologicals is a registered trademark of Serologicals Royalty Company.